Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion type Assertion NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_head.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion description "[These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion evidence source_evidence_literature NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion SIO_000772 20498641 NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion wasDerivedFrom befree-2016 NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.
- NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_assertion wasGeneratedBy ECO_0000203 NP814300.RAVNzqwNJ9g52xzwaPzrh-6NlEamIwCp1znS00Zc2zjBw130_provenance.